Apotea AB (publ)STU:V30 +0.74%18 Market Cap is €700.8 Mil as of Jul. 11, 2026. GuruFocus rates STU:V30 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 695 Healthcare Providers & Services companies, Apotea AB (publ) ranks better than 77.84% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Apotea AB (publ)'s share price for the quarter that ended in Mar. 2026 was €5.823. Apotea AB (publ)'s Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 104.1 Mil. Therefore, Apotea AB (publ)'s market cap for the quarter that ended in Mar. 2026 was €606.0 Mil.
Apotea AB (publ)'s quarterly market cap
increased
from Sep. 2025 (€815.1 Mil) to Dec. 2025 (€883.8 Mil) but then
declined
from Dec. 2025 (€883.8 Mil) to Mar. 2026 (€606.0 Mil).
Apotea AB (publ)'s annual market cap
increased
from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€755.0 Mil) and
increased
from Dec. 2024 (€755.0 Mil) to Dec. 2025 (€883.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Apotea AB (publ)'s Enterprise Value for Today is €719.3 Mil.
Apotea AB (publ) (STU:V30) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Apotea AB (publ) Market Cap Related Terms
Apotea AB (publ) Market Cap Historical Data
* Premium members only.
The historical data trend for Apotea AB (publ)'s Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Market Cap distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Apotea AB (publ)'s Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) (STU:V30) has a Market Cap of €700.8 Mil as of Jul. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Apotea AB (publ) and its competitors. According to the industry distribution chart, Apotea AB (publ) ranks #154 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 22.2%.
Is Apotea AB (publ)'s Market Cap too high?
Apotea AB (publ)'s current Market Cap is €700.8 Mil. Based on the distribution chart, Apotea AB (publ) ranks #154 out of 695 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #154 out of 695 companies for Market Cap. This places Apotea AB (publ) in the top 22% of its industry — outperforming the majority of peers. The industry median Market Cap is 99.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 99.66, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 99.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current Market Cap is €700.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (STU:V30) has a current Market Cap of €700.8 Mil. The current Market Cap is €700.8 Mil. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Apotea AB (publ) (STU:V30), the current Market Cap is €700.8 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for STU:V30
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:V30 has been successfully added to your 
